BioNTech (BNTX)
(Delayed Data from NSDQ)
$91.67 USD
-0.39 (-0.42%)
Updated May 10, 2024 04:00 PM ET
After-Market: $91.71 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth F Momentum F VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
BNTX 91.67 -0.39(-0.42%)
Will BNTX be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for BNTX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BNTX
Why Earnings Season Could Be Great for BioNTech (BNTX)
Pfizer (PFE) Q1 Earnings & Sales Top, EPS Guidance Raised
BNTX: What are Zacks experts saying now?
Zacks Private Portfolio Services
BioNTech (BNTX) to Report Q1 Earnings: Is a Beat in Store?
Here's How to Play Pfizer (PFE) Stock Ahead of Q1 Earnings
Will Novavax's (NVAX) Strategic Reshaping Curb Cash Burn?
Other News for BNTX
Novavax hits 52-week high as Sanofi deal brings upgrades (update)
Novavax hits a 52-week high as Sanofi deal prompts J.P. Morgan upgrade
Analysts Conflicted on These Healthcare Names: BioNTech SE (BNTX), Xenon (XENE) and BioLife Solutions (BLFS)
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
Biotech Alert: Searches spiking for these stocks today